Retinal Dystrophy Treatment Market 2027 By Type, Therapy, Treatment, Route of administration, Distribution channels,Impact of covid-19 pandemic. | The Insight Partners

Retinal Dystrophy Treatment Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type (Peripheral Dystrophy, Central Dystrophy); Therapy (Magnetic Therapy, Gene Therapy); Treatment (Drugs, Surgery); Route of administration (Oral, Topical, Other); Distribution channels (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies),Impact of covid-19 pandemic.

Report Code: TIPRE00015288 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Retinal dystrophy is a chronic disorder of visual function. This visual impairment condition is associated with deteriorating vision in one or both eyes. Retinal dystrophies are mostly genetic and are passed down from parents. Generally, retinal dystrophy is a genetically heterogeneous disorder which leads to blindness. Degeneration of different cells within the retina are the main cause of retinal dystrophies. Retinal dystrophy is an inherited eye disorder that resulted in damages of functional cells in the retina that transmits light from the eye to the brain through the optic nerve. Retinal dystrophy patients generally show symptoms by age 20 with reduced color and central vision. Common signs and symptoms associated with this disorder includes color or night blindness, tunnel vision, and subsequent progression to complete blindness. Retinal cell types involved in the retinal dystrophies may also include the rods and cones structures on retina of the eye.

MARKET DYNAMICS

Market for retinal dystrophy treatment market is driving due to factors such as Increase in special designation from the regulatory authorities, huge financial support to the researchers for developing novel therapies, high demand of disease specific novel treatment and advancement in treatment such as gene therapy and retinal transplantation in order to improve the vision. However, treatment by Surgery may alter the aesthetic aspects and function of the eye that can be the can be the challenging factor for the growth of this market and low healthcare budget in some developing countries is expected to hamper the market growth.

MARKET SCOPE

The Retinal Dystrophy Treatment market analysis to 2027 is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Retinal Dystrophy Treatment market with detailed market segmentation by type, therapy, treatment, route of administration and distribution channels. The Retinal Dystrophy Treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Retinal Dystrophy Treatment market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Retinal Dystrophy Treatment market is segmented on the basis of type, therapy, treatment, route of administration and distribution channels. Based on type, the market is segmented as peripheral dystrophy, central dystrophy. Based on therapy, market is segmented as magnetic therapy, gene therapy. Based on treatment, market is segmented as drugs, and surgery. Based on routes of administration, market is segmented into oral, topical, other. Based on distribution channel, market is segmented as hospital pharmacies, retail pharmacies, and online pharmacies.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Retinal Dystrophy Treatment market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Retinal Dystrophy Treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Retinal Dystrophy Treatment market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Retinal Dystrophy Treatment market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Retinal Dystrophy Treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Retinal Dystrophy Treatment market are anticipated to have lucrative growth opportunities in the future with the rising demand for Retinal Dystrophy Treatment in the global market. Below mentioned is the list of few companies engaged in the Retinal Dystrophy Treatment market.

The report also includes the profiles of key players in Retinal Dystrophy Treatment market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Spark Therapeutics, Inc
  •  Novartis AG
  •  Biogen
  •  HORAMA S.A.
  •  MeiraGTx Limited
  •  ReNeuron Group plc
  •  Retinagenix, LLC
  •  Novelion Therapeutics Inc.
  •  IVERIC bio
  •  Reflection Biotechnologies

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Retinal Dystrophy Treatment Market - By Type
1.3.2 Retinal Dystrophy Treatment Market - By Therapy
1.3.3 Retinal Dystrophy Treatment Market - By Treatment
1.3.4 Retinal Dystrophy Treatment Market - By Route of administration
1.3.5 Retinal Dystrophy Treatment Market - By Distribution channels
1.3.6 Retinal Dystrophy Treatment Market - By Region
1.3.6.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. RETINAL DYSTROPHY TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. RETINAL DYSTROPHY TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. RETINAL DYSTROPHY TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. RETINAL DYSTROPHY TREATMENT - GLOBAL MARKET OVERVIEW
6.2. RETINAL DYSTROPHY TREATMENT - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. RETINAL DYSTROPHY TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 – TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. PERIPHERAL DYSTROPHY
7.3.1. Overview
7.3.2. Peripheral Dystrophy Market Forecast and Analysis
7.4. CENTRAL DYSTROPHY
7.4.1. Overview
7.4.2. Central Dystrophy Market Forecast and Analysis
8. RETINAL DYSTROPHY TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 – THERAPY
8.1. OVERVIEW
8.2. THERAPY MARKET FORECASTS AND ANALYSIS
8.3. MAGNETIC THERAPY
8.3.1. Overview
8.3.2. Magnetic Therapy Market Forecast and Analysis
8.4. GENE THERAPY
8.4.1. Overview
8.4.2. Gene Therapy Market Forecast and Analysis
9. RETINAL DYSTROPHY TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 – TREATMENT
9.1. OVERVIEW
9.2. TREATMENT MARKET FORECASTS AND ANALYSIS
9.3. DRUGS
9.3.1. Overview
9.3.2. Drugs Market Forecast and Analysis
9.4. SURGERY
9.4.1. Overview
9.4.2. Surgery Market Forecast and Analysis
10. RETINAL DYSTROPHY TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 – ROUTE OF ADMINISTRATION
10.1. OVERVIEW
10.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
10.3. ORAL
10.3.1. Overview
10.3.2. Oral Market Forecast and Analysis
10.4. TOPICAL
10.4.1. Overview
10.4.2. Topical Market Forecast and Analysis
10.5. OTHER
10.5.1. Overview
10.5.2. Other Market Forecast and Analysis
11. RETINAL DYSTROPHY TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 – DISTRIBUTION CHANNELS
11.1. OVERVIEW
11.2. DISTRIBUTION CHANNELS MARKET FORECASTS AND ANALYSIS
11.3. HOSPITAL PHARMACIES
11.3.1. Overview
11.3.2. Hospital Pharmacies Market Forecast and Analysis
11.4. RETAIL PHARMACIES
11.4.1. Overview
11.4.2. Retail Pharmacies Market Forecast and Analysis
11.5. ONLINE PHARMACIES
11.5.1. Overview
11.5.2. Online Pharmacies Market Forecast and Analysis
12. RETINAL DYSTROPHY TREATMENT MARKET REVENUE AND FORECASTS TO 2027 – GEOGRAPHICAL ANALYSIS
12.1. NORTH AMERICA
12.1.1 North America Retinal Dystrophy Treatment Market Overview
12.1.2 North America Retinal Dystrophy Treatment Market Forecasts and Analysis
12.1.3 North America Retinal Dystrophy Treatment Market Forecasts and Analysis - By Type
12.1.4 North America Retinal Dystrophy Treatment Market Forecasts and Analysis - By Therapy
12.1.5 North America Retinal Dystrophy Treatment Market Forecasts and Analysis - By Treatment
12.1.6 North America Retinal Dystrophy Treatment Market Forecasts and Analysis - By Route of administration
12.1.7 North America Retinal Dystrophy Treatment Market Forecasts and Analysis - By Distribution channels
12.1.8 North America Retinal Dystrophy Treatment Market Forecasts and Analysis - By Countries
12.1.8.1 United States Retinal Dystrophy Treatment Market
12.1.8.1.1 United States Retinal Dystrophy Treatment Market by Type
12.1.8.1.2 United States Retinal Dystrophy Treatment Market by Therapy
12.1.8.1.3 United States Retinal Dystrophy Treatment Market by Treatment
12.1.8.1.4 United States Retinal Dystrophy Treatment Market by Route of administration
12.1.8.1.5 United States Retinal Dystrophy Treatment Market by Distribution channels
12.1.8.2 Canada Retinal Dystrophy Treatment Market
12.1.8.2.1 Canada Retinal Dystrophy Treatment Market by Type
12.1.8.2.2 Canada Retinal Dystrophy Treatment Market by Therapy
12.1.8.2.3 Canada Retinal Dystrophy Treatment Market by Treatment
12.1.8.2.4 Canada Retinal Dystrophy Treatment Market by Route of administration
12.1.8.2.5 Canada Retinal Dystrophy Treatment Market by Distribution channels
12.1.8.3 Mexico Retinal Dystrophy Treatment Market
12.1.8.3.1 Mexico Retinal Dystrophy Treatment Market by Type
12.1.8.3.2 Mexico Retinal Dystrophy Treatment Market by Therapy
12.1.8.3.3 Mexico Retinal Dystrophy Treatment Market by Treatment
12.1.8.3.4 Mexico Retinal Dystrophy Treatment Market by Route of administration
12.1.8.3.5 Mexico Retinal Dystrophy Treatment Market by Distribution channels
12.2. EUROPE
12.2.1 Europe Retinal Dystrophy Treatment Market Overview
12.2.2 Europe Retinal Dystrophy Treatment Market Forecasts and Analysis
12.2.3 Europe Retinal Dystrophy Treatment Market Forecasts and Analysis - By Type
12.2.4 Europe Retinal Dystrophy Treatment Market Forecasts and Analysis - By Therapy
12.2.5 Europe Retinal Dystrophy Treatment Market Forecasts and Analysis - By Treatment
12.2.6 Europe Retinal Dystrophy Treatment Market Forecasts and Analysis - By Route of administration
12.2.7 Europe Retinal Dystrophy Treatment Market Forecasts and Analysis - By Distribution channels
12.2.8 Europe Retinal Dystrophy Treatment Market Forecasts and Analysis - By Countries
12.2.8.1 Germany Retinal Dystrophy Treatment Market
12.2.8.1.1 Germany Retinal Dystrophy Treatment Market by Type
12.2.8.1.2 Germany Retinal Dystrophy Treatment Market by Therapy
12.2.8.1.3 Germany Retinal Dystrophy Treatment Market by Treatment
12.2.8.1.4 Germany Retinal Dystrophy Treatment Market by Route of administration
12.2.8.1.5 Germany Retinal Dystrophy Treatment Market by Distribution channels
12.2.8.2 France Retinal Dystrophy Treatment Market
12.2.8.2.1 France Retinal Dystrophy Treatment Market by Type
12.2.8.2.2 France Retinal Dystrophy Treatment Market by Therapy
12.2.8.2.3 France Retinal Dystrophy Treatment Market by Treatment
12.2.8.2.4 France Retinal Dystrophy Treatment Market by Route of administration
12.2.8.2.5 France Retinal Dystrophy Treatment Market by Distribution channels
12.2.8.3 Italy Retinal Dystrophy Treatment Market
12.2.8.3.1 Italy Retinal Dystrophy Treatment Market by Type
12.2.8.3.2 Italy Retinal Dystrophy Treatment Market by Therapy
12.2.8.3.3 Italy Retinal Dystrophy Treatment Market by Treatment
12.2.8.3.4 Italy Retinal Dystrophy Treatment Market by Route of administration
12.2.8.3.5 Italy Retinal Dystrophy Treatment Market by Distribution channels
12.2.8.4 Spain Retinal Dystrophy Treatment Market
12.2.8.4.1 Spain Retinal Dystrophy Treatment Market by Type
12.2.8.4.2 Spain Retinal Dystrophy Treatment Market by Therapy
12.2.8.4.3 Spain Retinal Dystrophy Treatment Market by Treatment
12.2.8.4.4 Spain Retinal Dystrophy Treatment Market by Route of administration
12.2.8.4.5 Spain Retinal Dystrophy Treatment Market by Distribution channels
12.2.8.5 United Kingdom Retinal Dystrophy Treatment Market
12.2.8.5.1 United Kingdom Retinal Dystrophy Treatment Market by Type
12.2.8.5.2 United Kingdom Retinal Dystrophy Treatment Market by Therapy
12.2.8.5.3 United Kingdom Retinal Dystrophy Treatment Market by Treatment
12.2.8.5.4 United Kingdom Retinal Dystrophy Treatment Market by Route of administration
12.2.8.5.5 United Kingdom Retinal Dystrophy Treatment Market by Distribution channels
12.2.8.6 Rest of Europe Retinal Dystrophy Treatment Market
12.2.8.6.1 Rest of Europe Retinal Dystrophy Treatment Market by Type
12.2.8.6.2 Rest of Europe Retinal Dystrophy Treatment Market by Therapy
12.2.8.6.3 Rest of Europe Retinal Dystrophy Treatment Market by Treatment
12.2.8.6.4 Rest of Europe Retinal Dystrophy Treatment Market by Route of administration
12.2.8.6.5 Rest of Europe Retinal Dystrophy Treatment Market by Distribution channels
12.3. ASIA-PACIFIC
12.3.1 Asia-Pacific Retinal Dystrophy Treatment Market Overview
12.3.2 Asia-Pacific Retinal Dystrophy Treatment Market Forecasts and Analysis
12.3.3 Asia-Pacific Retinal Dystrophy Treatment Market Forecasts and Analysis - By Type
12.3.4 Asia-Pacific Retinal Dystrophy Treatment Market Forecasts and Analysis - By Therapy
12.3.5 Asia-Pacific Retinal Dystrophy Treatment Market Forecasts and Analysis - By Treatment
12.3.6 Asia-Pacific Retinal Dystrophy Treatment Market Forecasts and Analysis - By Route of administration
12.3.7 Asia-Pacific Retinal Dystrophy Treatment Market Forecasts and Analysis - By Distribution channels
12.3.8 Asia-Pacific Retinal Dystrophy Treatment Market Forecasts and Analysis - By Countries
12.3.8.1 Australia Retinal Dystrophy Treatment Market
12.3.8.1.1 Australia Retinal Dystrophy Treatment Market by Type
12.3.8.1.2 Australia Retinal Dystrophy Treatment Market by Therapy
12.3.8.1.3 Australia Retinal Dystrophy Treatment Market by Treatment
12.3.8.1.4 Australia Retinal Dystrophy Treatment Market by Route of administration
12.3.8.1.5 Australia Retinal Dystrophy Treatment Market by Distribution channels
12.3.8.2 China Retinal Dystrophy Treatment Market
12.3.8.2.1 China Retinal Dystrophy Treatment Market by Type
12.3.8.2.2 China Retinal Dystrophy Treatment Market by Therapy
12.3.8.2.3 China Retinal Dystrophy Treatment Market by Treatment
12.3.8.2.4 China Retinal Dystrophy Treatment Market by Route of administration
12.3.8.2.5 China Retinal Dystrophy Treatment Market by Distribution channels
12.3.8.3 India Retinal Dystrophy Treatment Market
12.3.8.3.1 India Retinal Dystrophy Treatment Market by Type
12.3.8.3.2 India Retinal Dystrophy Treatment Market by Therapy
12.3.8.3.3 India Retinal Dystrophy Treatment Market by Treatment
12.3.8.3.4 India Retinal Dystrophy Treatment Market by Route of administration
12.3.8.3.5 India Retinal Dystrophy Treatment Market by Distribution channels
12.3.8.4 Japan Retinal Dystrophy Treatment Market
12.3.8.4.1 Japan Retinal Dystrophy Treatment Market by Type
12.3.8.4.2 Japan Retinal Dystrophy Treatment Market by Therapy
12.3.8.4.3 Japan Retinal Dystrophy Treatment Market by Treatment
12.3.8.4.4 Japan Retinal Dystrophy Treatment Market by Route of administration
12.3.8.4.5 Japan Retinal Dystrophy Treatment Market by Distribution channels
12.3.8.5 South Korea Retinal Dystrophy Treatment Market
12.3.8.5.1 South Korea Retinal Dystrophy Treatment Market by Type
12.3.8.5.2 South Korea Retinal Dystrophy Treatment Market by Therapy
12.3.8.5.3 South Korea Retinal Dystrophy Treatment Market by Treatment
12.3.8.5.4 South Korea Retinal Dystrophy Treatment Market by Route of administration
12.3.8.5.5 South Korea Retinal Dystrophy Treatment Market by Distribution channels
12.3.8.6 Rest of Asia-Pacific Retinal Dystrophy Treatment Market
12.3.8.6.1 Rest of Asia-Pacific Retinal Dystrophy Treatment Market by Type
12.3.8.6.2 Rest of Asia-Pacific Retinal Dystrophy Treatment Market by Therapy
12.3.8.6.3 Rest of Asia-Pacific Retinal Dystrophy Treatment Market by Treatment
12.3.8.6.4 Rest of Asia-Pacific Retinal Dystrophy Treatment Market by Route of administration
12.3.8.6.5 Rest of Asia-Pacific Retinal Dystrophy Treatment Market by Distribution channels
12.4. MIDDLE EAST AND AFRICA
12.4.1 Middle East and Africa Retinal Dystrophy Treatment Market Overview
12.4.2 Middle East and Africa Retinal Dystrophy Treatment Market Forecasts and Analysis
12.4.3 Middle East and Africa Retinal Dystrophy Treatment Market Forecasts and Analysis - By Type
12.4.4 Middle East and Africa Retinal Dystrophy Treatment Market Forecasts and Analysis - By Therapy
12.4.5 Middle East and Africa Retinal Dystrophy Treatment Market Forecasts and Analysis - By Treatment
12.4.6 Middle East and Africa Retinal Dystrophy Treatment Market Forecasts and Analysis - By Route of administration
12.4.7 Middle East and Africa Retinal Dystrophy Treatment Market Forecasts and Analysis - By Distribution channels
12.4.8 Middle East and Africa Retinal Dystrophy Treatment Market Forecasts and Analysis - By Countries
12.4.8.1 South Africa Retinal Dystrophy Treatment Market
12.4.8.1.1 South Africa Retinal Dystrophy Treatment Market by Type
12.4.8.1.2 South Africa Retinal Dystrophy Treatment Market by Therapy
12.4.8.1.3 South Africa Retinal Dystrophy Treatment Market by Treatment
12.4.8.1.4 South Africa Retinal Dystrophy Treatment Market by Route of administration
12.4.8.1.5 South Africa Retinal Dystrophy Treatment Market by Distribution channels
12.4.8.2 Saudi Arabia Retinal Dystrophy Treatment Market
12.4.8.2.1 Saudi Arabia Retinal Dystrophy Treatment Market by Type
12.4.8.2.2 Saudi Arabia Retinal Dystrophy Treatment Market by Therapy
12.4.8.2.3 Saudi Arabia Retinal Dystrophy Treatment Market by Treatment
12.4.8.2.4 Saudi Arabia Retinal Dystrophy Treatment Market by Route of administration
12.4.8.2.5 Saudi Arabia Retinal Dystrophy Treatment Market by Distribution channels
12.4.8.3 U.A.E Retinal Dystrophy Treatment Market
12.4.8.3.1 U.A.E Retinal Dystrophy Treatment Market by Type
12.4.8.3.2 U.A.E Retinal Dystrophy Treatment Market by Therapy
12.4.8.3.3 U.A.E Retinal Dystrophy Treatment Market by Treatment
12.4.8.3.4 U.A.E Retinal Dystrophy Treatment Market by Route of administration
12.4.8.3.5 U.A.E Retinal Dystrophy Treatment Market by Distribution channels
12.4.8.4 Rest of Middle East and Africa Retinal Dystrophy Treatment Market
12.4.8.4.1 Rest of Middle East and Africa Retinal Dystrophy Treatment Market by Type
12.4.8.4.2 Rest of Middle East and Africa Retinal Dystrophy Treatment Market by Therapy
12.4.8.4.3 Rest of Middle East and Africa Retinal Dystrophy Treatment Market by Treatment
12.4.8.4.4 Rest of Middle East and Africa Retinal Dystrophy Treatment Market by Route of administration
12.4.8.4.5 Rest of Middle East and Africa Retinal Dystrophy Treatment Market by Distribution channels
12.5. SOUTH AND CENTRAL AMERICA
12.5.1 South and Central America Retinal Dystrophy Treatment Market Overview
12.5.2 South and Central America Retinal Dystrophy Treatment Market Forecasts and Analysis
12.5.3 South and Central America Retinal Dystrophy Treatment Market Forecasts and Analysis - By Type
12.5.4 South and Central America Retinal Dystrophy Treatment Market Forecasts and Analysis - By Therapy
12.5.5 South and Central America Retinal Dystrophy Treatment Market Forecasts and Analysis - By Treatment
12.5.6 South and Central America Retinal Dystrophy Treatment Market Forecasts and Analysis - By Route of administration
12.5.7 South and Central America Retinal Dystrophy Treatment Market Forecasts and Analysis - By Distribution channels
12.5.8 South and Central America Retinal Dystrophy Treatment Market Forecasts and Analysis - By Countries
12.5.8.1 Brazil Retinal Dystrophy Treatment Market
12.5.8.1.1 Brazil Retinal Dystrophy Treatment Market by Type
12.5.8.1.2 Brazil Retinal Dystrophy Treatment Market by Therapy
12.5.8.1.3 Brazil Retinal Dystrophy Treatment Market by Treatment
12.5.8.1.4 Brazil Retinal Dystrophy Treatment Market by Route of administration
12.5.8.1.5 Brazil Retinal Dystrophy Treatment Market by Distribution channels
12.5.8.2 Argentina Retinal Dystrophy Treatment Market
12.5.8.2.1 Argentina Retinal Dystrophy Treatment Market by Type
12.5.8.2.2 Argentina Retinal Dystrophy Treatment Market by Therapy
12.5.8.2.3 Argentina Retinal Dystrophy Treatment Market by Treatment
12.5.8.2.4 Argentina Retinal Dystrophy Treatment Market by Route of administration
12.5.8.2.5 Argentina Retinal Dystrophy Treatment Market by Distribution channels
12.5.8.3 Rest of South and Central America Retinal Dystrophy Treatment Market
12.5.8.3.1 Rest of South and Central America Retinal Dystrophy Treatment Market by Type
12.5.8.3.2 Rest of South and Central America Retinal Dystrophy Treatment Market by Therapy
12.5.8.3.3 Rest of South and Central America Retinal Dystrophy Treatment Market by Treatment
12.5.8.3.4 Rest of South and Central America Retinal Dystrophy Treatment Market by Route of administration
12.5.8.3.5 Rest of South and Central America Retinal Dystrophy Treatment Market by Distribution channels
13. IMPACT OF COVID-19 PANDEMIC ON GLOBAL RETINAL DYSTROPHY TREATMENT MARKET
13.1 North America
13.2 Europe
13.3 Asia-Pacific
13.4 Rest of the World
14. INDUSTRY LANDSCAPE
14.1. MERGERS AND ACQUISITIONS
14.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
14.3. NEW PRODUCT LAUNCHES
14.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
15. RETINAL DYSTROPHY TREATMENT MARKET, KEY COMPANY PROFILES
15.1. SPARK THERAPEUTICS, INC.
15.1.1. Key Facts
15.1.2. Business Description
15.1.3. Products and Services
15.1.4. Financial Overview
15.1.5. SWOT Analysis
15.1.6. Key Developments
15.2. NOVARTIS AG
15.2.1. Key Facts
15.2.2. Business Description
15.2.3. Products and Services
15.2.4. Financial Overview
15.2.5. SWOT Analysis
15.2.6. Key Developments
15.3. BIOGEN
15.3.1. Key Facts
15.3.2. Business Description
15.3.3. Products and Services
15.3.4. Financial Overview
15.3.5. SWOT Analysis
15.3.6. Key Developments
15.4. HORAMA S.A.
15.4.1. Key Facts
15.4.2. Business Description
15.4.3. Products and Services
15.4.4. Financial Overview
15.4.5. SWOT Analysis
15.4.6. Key Developments
15.5. MEIRAGTX LIMITED
15.5.1. Key Facts
15.5.2. Business Description
15.5.3. Products and Services
15.5.4. Financial Overview
15.5.5. SWOT Analysis
15.5.6. Key Developments
15.6. RENEURON GROUP PLC.
15.6.1. Key Facts
15.6.2. Business Description
15.6.3. Products and Services
15.6.4. Financial Overview
15.6.5. SWOT Analysis
15.6.6. Key Developments
15.7. RETINAGENIX, LLC.
15.7.1. Key Facts
15.7.2. Business Description
15.7.3. Products and Services
15.7.4. Financial Overview
15.7.5. SWOT Analysis
15.7.6. Key Developments
15.8. NOVELION THERAPEUTICS INC.
15.8.1. Key Facts
15.8.2. Business Description
15.8.3. Products and Services
15.8.4. Financial Overview
15.8.5. SWOT Analysis
15.8.6. Key Developments
15.9. IVERIC BIO.
15.9.1. Key Facts
15.9.2. Business Description
15.9.3. Products and Services
15.9.4. Financial Overview
15.9.5. SWOT Analysis
15.9.6. Key Developments
15.10. REFLECTION BIOTECHNOLOGIES
15.10.1. Key Facts
15.10.2. Business Description
15.10.3. Products and Services
15.10.4. Financial Overview
15.10.5. SWOT Analysis
15.10.6. Key Developments
16. APPENDIX
16.1. ABOUT THE INSIGHT PARTNERS
16.2. GLOSSARY OF TERMS
The List of Companies

1. Spark Therapeutics, Inc
2. Novartis AG
3. Biogen
4. HORAMA S.A.
5. MeiraGTx Limited
6. ReNeuron Group plc
7. Retinagenix, LLC
8. Novelion Therapeutics Inc.
9. IVERIC bio
10. Reflection Biotechnologies
TIPRE00015288
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking